MNDT yields 8.75% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, MNDT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MNDT + PFE for your $10,000?
Mandiant, Inc. engages in the provision of cyber security solutions. The company, through the Mandiant Advantage SaaS platform, offers threat intelligence, security validation, attack surface management and security automation, as well as managed and consulting services. It also provides Advantage Platform, a multi-vendor XDR platform that delivers the company's expertise and frontline intelligence to security teams; Managed Defense, a solution with comprehensive protection from advanced and emerging threats; and Mandiant Academy, which provides cyber security training services. In addition, the company offers incident response, ransomware, risk management, targeted attack testing, cyber defense transformation, identity first security, industrial control systems and operational technology, cloud architecture, cyber security due diligence, and threat intelligence services. It provides its solutions and services under the Mandiant brand to telecommunications, technology, financial services, public utilities, healthcare, and oil and gas industries, the Unites States and international governmental agencies, as well as educational and nonprofit organizations. The company was formerly known as FireEye, Inc. and changed its name to Mandiant, Inc. in October 2021. Mandiant, Inc. was incorporated in 2004 and is headquartered in Reston, Virginia.
Full MNDT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.